歡迎成為美安夥伴商店 無論網上或實體商店,我們都歡迎你加入 了解更多

HK$441.00

HK$8.82 現金回贈

凡從美安購滿HK$1300或以上的訂單,便可享有免費送貨優惠。 詳細內容

單罐裝(28次份量)

擁有健康的消化道對維持人體整體健康非常重要;而了解複雜的消化過程,對了解維持健康的消化道如何能促進免疫系統健康以及整體健康也非常重要。 NutriClean® 腸道營養纖維粉 有可口的莓味道,易於與水混合。此纖維粉含有可溶纖維、有助維持健康的益生菌以及必要的腸道養份。腸道為消化系統中主要的排泄部位,亦 是消化系統整體健康的主要決定因素。此產品配方所含的纖維及益生菌相互合作維持消化道健康,並同時有助減少乳糖不耐症。因此,美安香港的 NutriClean®...
詳細內容

益處

  • 有助保持消化系統健康
  • 鞏固健康腸道功能
  • 增強免疫力
  • 有助維持正常的腸道內菌-叢生態


不含麩質 - 本產品不含可檢測出之麩質*

素食品 - 本產品為素食產品

* 美國食品藥物監督管理局(FDA)將含有少於20PPM麩質的製成產品列為不含麩質

益處  

點擊以放大圖片

詳細資料

Product Brochure

擁有健康的消化道對維持人體整體健康非常重要;而了解複雜的消化過程,對了解維持健康的消化道如何能促進免疫系統健康以及整體健康也非常重要。

NutriClean® 腸道營養纖維粉 有可口的莓味道,易於與水混合。此纖維粉含有可溶纖維、有助維持健康的益生菌以及必要的腸道養份。腸道為消化系統中主要的排泄部位,亦 是消化系統整體健康的主要決定因素。此產品配方所含的纖維及益生菌相互合作維持消化道健康,並同時有助減少乳糖不耐症。因此,美安香港的 NutriClean® 腸道營養纖維粉不單提供高質素的可溶性纖維,還提供有益健康的益生菌,益生菌能維持腸道內的益菌數量,保持腸內微生物的平 衡。除此之外,只有乳酪及雪蓮(Kefir)才可找到益生菌。經過美安公司科學家的研究證明, NutriClean® 腸道營養纖維粉含有左旋麩醯胺酸 (L-Glutamine)、菊糖纖維(Inulin Fiber)、可溶性膳食纖維Fibersol-2和益生菌。本產品中所含的益生菌配方,能提供15億菌落數的健康微生物!眾所皆知,理想的健康從身體內 部的清潔開始,而腸道營養纖維粉可幫助你實現此理想!

美安香港產品安全及不含有害物質。其產品在美國製造,並於經美國食品及藥物管理局檢測的設備生產,符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

詳細資料  

點擊以放大圖片

成分

左旋麩醯胺酸
含高蛋白質的食物如肉類、魚、豆及奶類產品等都是麩醯胺酸的絕佳來源。麩醯胺酸是一種有助恢復健康的胺基酸,是消化道的能源。麩醯胺酸能有助維持正常的膽固醇水平、正常的血糖水平及促進免疫系統健康,從而支援整體健康。大量運動、感染、手術或創傷均能損耗人體的麩醯胺酸儲備,尤其是肌肉細胞內的麩醯胺酸。由於腸道細胞使用麩醯胺酸作能源,左旋麩醯胺酸補充品一直被用作促進消化健康。

菊糖纖維(菊苣根的低聚果糖萃取物)
菊糖纖維是一種益菌素纖維,益菌素(Prebiotics)是益菌的食物來源。菊糖或低聚果糖是澱粉形態的纖維,人體不能完全消化。當人體進食益菌素時,未能消化的部份為消化道的益菌提供養份。菊糖可促進益菌數量增長,如結腸-內的雙叉桿菌(bifidobacteria)。雙叉桿菌可抑制致病細菌的滋長。

Fibersol-2(可溶性纖維葡萄糖聚合物複合物)
Fibersol-2 是一種水溶性纖維,對消除廢物及腸道清洗有正面的效果,因此,或有助於穩定血壓。這種創新的食用纖維是透過玉米粉高溫分解及穩定酵素水解而製成的噴霧風乾粉末。Fibersol-2被美國食品藥物主管機構給予「安全可靠」的檢驗標記,與麥芽糊精同樣安全,易於溶於水中,而且不含任何味道。

Fibersol-2的黏性低,水溶性高,以及吸水度低,溶於水中成為清澈的溶液。

研究顯示Fibersol-2對人體健康有益,其中包括對消化道、血糖及膽固醇水平的好處。生理學上,Fibersol-2顯示能促進正常的腸道活動規律及排便量。Fibersol-2能增加大腸中的益菌數量。

由於Fibersol-2 對健康的益處及其廣泛的用途,它在日本被應用在大量「具有特別健康用途的食品」(Foods for Specified Health Use)。在日本,巿面售賣含有 Fibersol-2 的飲品、曲奇餅及香腸等均標明聲稱有促進「腸道規律」、「控制血糖」及「降低膽固醇」效果。

益生菌混合物(包括嗜乳酸桿菌、胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌)
益生菌如嗜酸桿菌是特定形式的細菌,亦稱之為「益菌」。事實上,這些細菌有助維持健康的消化道功能。益菌量減少是正常的,但益菌量必須維持在適當的水平,以壓倒其他致病的細菌,如益菌量下降,其他細菌則會開始大量滋長。透過除去其他細菌及酵母菌的功能,嗜酸桿菌(及其他益菌如胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌)在防止腸胃毛病上也擔當重要的角色。

總括來說,益生菌支援免疫系統確認入侵生物的能力。長期服用益菌,免疫系統中幾種主要的「戰士」,包括吞噬細胞、免疫球蛋白及細胞激素都獲益。

常見問答

NutriClean 腸道營養纖維粉和一般市面商店購買的纖維粉有何不同?
NutriClean腸道營養纖維粉是腸道健康的革命性創新產品。大多數超市和藥房售賣的纖維產品,都或有助通便,然而卻缺少了一些重要成份。不像巿面一般的纖維粉僅含簡單的助瀉纖維,美安香港的NutriClean腸道營養纖維粉含有稱為左旋麩醯胺酸(L-Glutamine)的養份,為消化系統運作提供能量來源。此產品還含有兩種經過研究證明的高品質纖維,即Fibersol-2與菊糖纖維。我們的纖維粉配方中每一份含有15億菌落數的益生菌,這些益生菌在直接或間接保持整體健康上擔當不可或缺的角色。

為什麼纖維對整體健康如此重要?
很不幸的是,現代人的生活方式使得一般人從他們的飲食中沒有獲得足夠的纖維素。這絕不是好事,因為纖維事實上應該是飲食中最重要的構成要素之一,然而卻往往被人們忽略了。纖維的益處包括促進腸道蠕動、增加飽肚感、促進排便以維持腸道運作的規律性。

益生菌
(probiotics) 是什麼?
益生菌(probiotics)是一種細菌,但這種細菌和那些因不當飲食而累積在結腸內的不健康細菌不可混為一談。NutriClean™腸道營養纖維粉配方中所含的益生菌能抗衡多餘的有害細菌,為最佳的整體保健鋪下健康之路。益生菌被發現有助於維持理想的消化系統功能。幾世紀以來,世界各地的文化諸如格魯吉亞、亞塞拜彊、厄瓜多爾和喜馬拉雅山脈地帶,已廣泛使用各種不同種類的健康菌叢(益生菌)來維持身體的健康。益生菌必須以每次攝取量超過10億菌落數最為有效,並且有規律性按時食用。NutriClean®腸道營養纖維粉配方中每一份含有15億菌落數的益生菌,包括嗜乳酸桿菌(Lactobacillus acidophilus)、胚芽乳酸桿菌(Lactobacillus plantarum)、酪蛋白乳酸桿菌(Lactobacillus casei)以及雙歧雙叉桿菌(Bifidobacteria bifidum)。

如何飲用 NutriClean 腸道營養纖維粉?
將一圓匙的NutriClean腸道營養纖維粉加入一杯237毫升的冷開水中加以攪拌,並即時飲用。使用本品時請多飲水。一天食用一匙美安香港的NutriClean腸道營養纖維粉,能提供9克每日所需的纖維,以補充日常飲食的不足。

腸道營養纖維粉和什麼產品一起使用可發揮最大功效?
本產品可配合任何其他營養保充品使用,視乎你的營養需要而定。如希望加強消化系統健康,可使用NutriClean腸道營養纖維粉與NutriClean益生菌配方、NutriClean 全方位蔬果精華、Ultimate Aloe™蘆薈汁及Isotonix®消化酵素沖飲;如希望抑制身體吸收碳水化合物,可同時使用TLS® CORE高效修身配方控醣‧控脂二合一。

使用
NutriClean腸道營養纖維粉安全嗎?
此產品安全及不含有害物質。本產品在美國製造,並於經美國食品及藥物管理局檢測的設備生產,符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

科學

(Fibersol-2)

  • Satouchi M et al, "Effects of indigestible dextrin on bowel movements," Japanese J Nutr , 51:31-37, 1993.
  • Tokunaga K and Matsuoka A, "Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society , 42:61-65, 1999.
  • Wakabayashi S et al, "Effects of indigestible dextrin on glucose tolerance in rats," J Endocrinology , 144:533-538, 1995.
  • Watanabe O et al, "Effects of galacto-oligosaccharide and indigestible dextrin on fat accumulation in broiler," Japanese Poultry Science , 30:35, 1993.

(Inulin)

  • Brighenti F, Casiraghi MC, Canzi E, Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 1999; 53:726-733.
  • Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther . 2001;15:1139–1145.
  • Davidson MH, Synecki C, Maki KC, Drennen KB. Effects of dietary inulin in serum lipids in men and women with hypercholesterolaemia. Nutr Res . 1998;3:503–17.
  • Ducros V, Arnaud J, Tahiri M, et al. Influence of short-chain fructo-oligosaccharides (sc-FOS) on absorption of Cu, Zn, and Se in healthy postmenopausal women. J Am Coll Nutr . 2005;24:30–7.
  • Giacco R, Clemente G, Luongo D, et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr . 2004;23:331–40.
  • Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr . 1999;82:23–30.
  • Menne E, Guggenbuhl N, Roberfroid M. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr. 2000; 130:1197-1199.
  • Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr . 2000;72:1570–5.
  • Pedersen A, Sandstrom B, van Amelsvoort JMM. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr . 1997;78:215–22.
  • Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis. 1997; 18:1371-1374.
  • Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr. 1998; 18:117-143.
  • Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998; 128:11-19.
  • Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr . 1998;52:436–40.
  • Tahiri M, Tressol JC, Arnaud J, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr . 2003;77:449–457.
  • Tahiri M, Tressol JC, Arnaud J, et al. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res . 2001;16:2152–2160.
  • van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr . 99;53:1–7.
  • Waligora-Dupriet AJ, Campeotto F, Nicolis I et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol . 2006 Sep 20 [Epub ahead of print]
  • Williams CM. Effects of inulin on lipid parameters in humans. J Nutr. 1999; 129(7 Suppl):1471S-1473S.
  • Williams CM, Jackson KG. Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr . 2002;87(suppl 2):S261–4.

(L-Glutamine)

  • Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr . 2000;30:78–84.
  • Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. JPEN J Parenter Enteral Nutr .1990;14(suppl 4):109S–113S.
  • Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28–33.
  • Den Hond E, Hiele M, Peeters M, et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. JPEN J Parenter Enteral Nutr . 1999;23:7–11.
  • Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg Forum . 1987;38:43–44.
  • Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg . 1995;82:749–751.
  • Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition . 2003;19:805-11.
  • Huffman FG, Walgren ME. L-Glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials . 2003;4:324-9. gut integrity. Lancet . 1993;341:1363–1365.
  • Shabert JK, Winslow C, Lacey JM, et al. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition . 1999;15:860–864.
  • van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. 1993 May 29;341(8857):1363-5.
  • Yang C, Li N, Li JS. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol . 2004;10:1992-4.
  • Zoli G, Care M, Falco F, et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease [abstract]. Gastroenterology . 1995;108:A766.

(Probiotic Blend)

  • Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000 Apr;54(4):288-97.
  • Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7.
  • Barone C, Pettinato R, Avola E, Alberti A, Greco D, Failla P, Romano C. Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children. Minerva Pediatr. 2000 Mar;52(3):161-5.
  • Bengmark S. Bacteria for optimal health. Nutrition. 2000 Jul-Aug;16(7-8):611-5.
  • Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S5-7.
  • Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998 Jan;42(1):2-7.
  • Biancone L, Pallone F. Current treatment modalities in active Crohn's disease. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):508-14.
  • Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon cancer. J Nutr. 2000 Feb;130(2S Suppl):410S-414S.
  • Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S18-22.
  • Cerrato PL. Can "healthy" bacteria ward off disease? RN. 2000 Apr;63(4):71-4.
  • Chin J, Turner B, Barchia I, Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):55-66.
  • Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999 May;69(5):1052S-1057S.
  • Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, Califano C, Dunn AM, Grassey C, Hinds G, Cervia J. Probiotics and immune response. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S22-5.
  • D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999;472:149-58.
  • Davidson GP, Butler RN. Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr. 2000 Oct;12(5):477-81.
  • de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000 Feb;71(2):405-11.
  • Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N, Postaire E. Immunity and probiotics. Immunol Today. 1999 Sep;20(9):387-90.
  • Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):279-92.
  • Dupont C. Bacterial flora in the infant and intestinal immunity: Implication and prospects for infant food with probiotics. Arch Pediatr. 2000 May;7 Suppl 2:252s-255s.
  • Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000 Feb;130(2S Suppl):403S-409S.
  • Folwaczny C. Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment? Z Gastroenterol. 2000 Jun;38(6):547-50.
  • Friedrich MJ. A bit of culture for children: probiotics may improve health and fight disease. JAMA. 2000 Sep 20;284(11):1365-6.
  • Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr. 2000 Feb;130(2S Suppl):391S-395S.
  • Gibson GR, McCartney AL. Modification of the gut flora by dietary means. Biochem Soc Trans. 1998 May;26(2):222-8.
  • Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents. 1999 Aug;12(4):287-92.
  • Goldin BR. Health benefits of probiotics. Br J Nutr. 1998 Oct;80(4):S203-7.
  • Gomez-Gil B, Roque A, Turnbull JF, Inglis V. A review on the use of microorganisms as probiotics. Rev Latinoam Microbiol. 1998 Jul-Dec;40(3-4):166-72.
  • Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S2-4.
  • Guslandi M. The relationship between gut microflora and intestinal inflammation. Can J Gastroenterol. 2000 Jan;14(1):32.
  • Heyman M. Effect of lactic acid bacteria on diarrheal diseases. J Am Coll Nutr. 2000 Apr;19(2 Suppl):137S-146S.
  • Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000 May;2(6):681-6.
  • Hoerr RA, Bostwick EF. Bioactive proteins and probiotic bacteria: modulators of nutritional health. Nutrition. 2000 Jul-Aug;16(7-8):711-3.
  • Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol. 1998 May 26;41(2):85-101.
  • Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr. 1999 May;53(5):339-50.
  • Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999 Summer;3(4):197-202.
  • Isolauri E. The use of probiotics in paediatrics. Hosp Med. 2000 Jan;61(1):6-7.
  • Kasper H. Protection against gastrointestinal diseases--present facts and future developments. Int J Food Microbiol. 1998 May 26;41(2):127-31.
  • Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics--a novel approach in the management of food allergy. Allergy. 1999 Sep;54(9):909-15.
  • Klaenhammer TR. Probiotic bacteria: today and tomorrow. J Nutr. 2000 Feb;130(2S Suppl):415S-416S. 40. Kochhar KP. Probiotics and gastrointestinal function in health and disease. Trop Gastroenterol. 2000 Jan-Mar;21(1):8-11.
  • LaMont JT. The renaissance of probiotics and prebiotics. Gastroenterology. 2000 Aug;119(2):291.
  • Levy J. Immunonutrition: the pediatric experience. Nutrition. 1998 Jul-Aug;14(7-8):641-7. 43. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999 Apr 10;318(7189):999-1003.
  • Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):67-73.
  • Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000;26(3):95-111.
  • Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000 Jan;30(1):10-3.
  • Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 1999 Jul;129(7 Suppl):1478S-82S.
  • Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 1999 Sep;65(9):3763-6.
  • Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S.
  • Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000 Feb;130(2S Suppl):396S-402S.
  • Saavedra JM. Probiotics plus antibiotics: regulating our bacterial environment. J Pediatr. 1999 Nov;135(5):535-7.
  • Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr. 2000 Feb;130(2S Suppl):384S-390S.
  • Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science. 2000 Aug 25;289(5483):1311-2.
  • Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis. 2000 May;6(2):107-15.
  • Studd C. Probiotic containing fermented milk supplement may improve the institution of early enteral nutrition. Crit Care Med. 2000 Apr;28(4):1255-6.
  • Szilagyi A. Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am J Clin Nutr. 1999 Jul;70(1):105-6.
  • Taylor GR, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr. 1998 Oct;80(4):S225-30.
  • Torrens JK, McWhinney PH. Probiotics and life-threatening infection. J Infect. 1999 Nov;39(3):246.
  • Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
  • Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):323-32.
  • Vanderhoof JA. Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S34-8.
  • Vilpponen-Salmela T, Alander M, Satokari R, Bjorkman P, Kontula P, Korpela R, Saxelin M, Mattila-Sandholm T, von Wright A. Probiotic bacteria and intestinal health: new methods of investigation. J Physiol Paris. 2000 Mar-Apr;94(2):157-8.
  • von Wright A, Salminen S. Probiotics: established effects and open questions. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1195-8.
  • Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):383-9.
  • Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Gopal PK, Gill HS. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol. 2000 Feb-Mar;38(2-3):153-61.

美安香港產品安全及不含有害物質。其產品在美國製造,並於經美國食品及藥物管理局檢測的設備生產,符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

評價

SHOP.COM 商品評論

評價此商店

CP值超級高

購物顧問

購物顧問是本產品的獨立經銷商。

日期 14/6/2018

先前幾次突然其來的腸胃炎,不管是吃什麼就吐什麼,拉什麼,一連好幾天,胃藥胃奶益生菌酵素吃了都沒用,結果先進纖維粉才泡一匙喝完沒多久就好一半,再泡一匙喝就完全好了,不吐也不拉了,讚嘆纖維粉,歌颂纖維粉。

我喜歡這味道。

日期 16/2/2018

Good

好喝

購物顧問

購物顧問是本產品的獨立經銷商。

日期 6/5/2016

好好喝,讚

我愛3吸

購物顧問

購物顧問是本產品的獨立經銷商。

日期 12/12/2015

吸水,吸糖,又吸油

必備

購物顧問

購物顧問是本產品的獨立經銷商。

日期 2/10/2015

吃完油膩的大餐之後必備!!! 吃完烤肉大餐必備!!!